Outcomes in African-American (AA) and White patients with newly diagnosed multiple myeloma receiving RVd-alone vs RVd + ASCT in determination: Efficacy, safety, and second primary malignancies (SPMS) Meeting Abstract

  

Authors:	Richardson, P. G.; Zonder, J. A.; Khan, A. M.; Jacobus, S. J.; Hassoun, H.; Anderson, L. D. Jr; Merz, L. E.; Zon, R. L.; Efebera, Y.; Buck, T.; Innis-Shelton, R. D.; Hartley-Brown, M. A.; Lonial, S.; Campagnaro, E. L.; Voorhees, P. M.; Orlowski, R. Z.; Libby, E. N.; Hurd, D. D.; Costello, C. L.; Raje, N. S.; Medvedova, E.; McCarthy, P. L.; Milner Milner, C. P.; Gasparetto, C.; Agha, M. E.; Gowin, K.; Kamble, R. T.; Jagannath, S.; Nathwani, N.; Alsina, M.; Giralt, S.; Laubach, J. P.; Nadeem, O.; Ghobrial, I. M.; Mo, C. C.; Samur, M. K.; Munshi, N. C.; Anderson, K. C.
Abstract Title:	Outcomes in African-American (AA) and White patients with newly diagnosed multiple myeloma receiving RVd-alone vs RVd + ASCT in determination: Efficacy, safety, and second primary malignancies (SPMS)
Meeting Title:	50th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
Journal Title:	Bone Marrow Transplantation
Volume:	59
Issue:	Suppl. 1
Meeting Dates:	2024 Apr 14-17
Meeting Location:	Glasgow, Scotland
ISSN:	0268-3369
Publisher:	Nature Publishing Group
Date Published:	2024-10-01
Start Page:	105
End Page:	107
Language:	English
ACCESSION:	WOS:001365375000117
PROVIDER:	wos
DOI:	10.1038/s41409-024-02347-7
Notes:	Meeting Abstract: O115 -- Hybrid Meeting -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/222643